Figure 7 Lymphangiogenesis in lymph nodes adjacent and contralateral to tumor-bearing sentinel lymph nodes. (A), (B) Double immunofluorescent

images of tyrosinase-related protein 1 (TRP-1; green) and lymphatic DMXAA concentration vessel endothelial hyaluronan receptor 1 (LYVE-1; red) in lymph nodes (LNs) adjacent (A) and contralateral (B) to tumor-bearing sentinel LNs (SLNs), showing an increase in LYVE-1-positive sinuses in the medulla. aLN, adjacent lymph node; cLN, contralateral find more lymph node; arrowhead, TRP-1-positive melanoma cells. Scale bar = 50 μm. (C) Measurement of LYVE-1-positive lymphatic sinus area in LNs adjacent and contralateral to tumor-bearing SLNs. Columns, mean; bar, standard error. *, P<0.001 relative to controls. Immunohistochemical interactions between VEGF-C and VEGFR-3 in tumor-associated LNs Recent studies demonstrated that VEGF-C/VEGFR-3 signaling promotes tumor lymphangiogenesis and contributes to the promotion of metastasis [13, 14]. We examined immunohistochemical interactions between VEGF-C and its receptor, Flt-4 (VEGFR-3), in tumor-associated LNs. First, we demonstrated VEGF-C mRNA expression in B16F10 melanoma cells and tumor-bearing LN tissues Selleckchem EPZ004777 by RT-PCR (Figure 8A). VEGF-C mRNA expression was evident in both cells and tissues. Immunofluorescent detection of VEGF-C revealed a cytoplasmic location

in B16F10 cells (Figure 8B). Next, we performed double immunofluorescent staining for VEGF-C and Flt-4 in primary melanoma of the tongue (Figure 8C), tumor-bearing SLNs (Figure 8D), and LNs adjacent to tumor-bearing SLNs (Figure 8E). In both tongue melanomas and tumor-bearing SLNs, close interaction was observed between VEGF-C-positive Amrubicin melanoma cells and Flt-4-positive lymphatic vessels. Adjacent LNs showed increased Flt-4-positive sinuses from the hilum to the medulla. Tumor-associated LNs without metastasis such as SLNs and LNs contralateral to metastatic SLNs also showed increased sinuses expressing Flt-4 (data not shown). In control LNs, anti-Flt-4 antibody was unreactive with lymphatic sinuses (data not shown). Figure 8 Correlation

between Vascular endothelial growth factor C and Fms-related tyrosine kinase expressions in tumor-associated lymph nodes. (A) Expression of Vascular endothelial growth factor C (VEGF-C) mRNA detected by reverse transcription PCR in B16/F10 cells and tumor-bearing lymph nodes (LNs). Glyceraldehyde-3-phosphate dehydrogenase expression was used as a loading control. (B) Immunofluorescence image of VEGF-C expression in B16/F10 cells. Scale bar = 50 μm. (C)-(E) Double immunofluorescence images using antibodies specific for VEGF-C (green) and Fms-related tyrosine kinase (Flt-4; red) in primary melanoma of the tongue (C), tumor-bearing sentinel LNs (D), and LNs adjacent (aLN) to tumor-bearing LNs (E). Photographs show an increase in Flt-4-positive lymphatic vessels and sinuses. Scale bars = 50 μm.